Luciferase-based protein denaturation assay for quantification of radiofrequency field-induced targeted hyperthermia: developing an intracellular thermometer.
Luciferase-based protein denaturation assay for quantification of radiofrequency field-induced targeted hyperthermia: developing an intracellular thermometer.
复制标题
DOI:
10.3109/02656736.2012.666318
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
Curley SA
中科院分区:
文献类型:
--
作者:
Raoof M;Zhu C;Kaluarachchi WD;Curley SA
Several studies have reported targeted hyperthermia at the cellular level using remote activation of nanoparticles by radiofrequency waves. To date, methods to quantify intracellular thermal dose have not been reported. In this report we study the relationship between radio wave exposure and luciferase denaturation with and without intracellular nanoparticles. The findings are used to devise a strategy to quantify targeted thermal dose in a primary human liver cancer cell line. Water-bath or non-invasive external RF generator (600W, 13.56 MHz) was used for hyperthermia exposures. Luciferase activity was measured using a bioluminescence assay and viability was assessed using Annexin V-FITC and Propidium iodide staining. Heat shock proteins were analyzed using western-blot analysis Duration-dependent luciferase denaturation was observed in SNU449 cells exposed to RF field that preceded measurable loss in viability. Loss of luciferase activity was higher in cetuximab-conjugated gold nanoparticle (C225-AuNP) treated cells. Using a standard curve from water-bath experiments, the intracellular thermal dose was calculated. Cells treated with C225-AuNP accumulated 6.07 times higher intracellular thermal dose than the untreated controls over initial 4 minutes of RF exposure. Cancer cells when exposed to an external RF field exhibit dose-dependent protein denaturation. Luciferase denaturation assay can be used to quantify thermal dose delivered after RF exposures to cancer cells with and without nanoparticles.
登录
查看更多内容
DOI:
10.1023/b:jtan.0000033212.93809.e1
发表时间:
2004-01-01
影响因子:
4.4
作者:
Michnik, A;Klos, A;Drzazga, Z
通讯作者:
Drzazga, Z
DOI:
10.1158/1078-0432.ccr-10-2055
发表时间:
2010-12-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Glazer ES;Zhu C;Massey KL;Thompson CS;Kaluarachchi WD;Hamir AN;Curley SA
通讯作者:
Curley SA
影响因子:
15
作者:
Gota, Chie;Okabe, Kohki;Uchiyama, Seiichi
通讯作者:
Uchiyama, Seiichi
影响因子:
17.1
作者:
Creixell, Mar;Bohorquez, Ana C.;Rinaldi, Carlos
通讯作者:
Rinaldi, Carlos
影响因子:
14.8
作者:
Kumar, S.;Aaron, J.;Sokolov, K.
通讯作者:
Sokolov, K.